Global Tumor / Cancer Markers Market to Reach $6.5 Billion by 2030
The global market for Tumor / Cancer Markers estimated at US$3.9 Billion in the year 2022, is projected to reach a revised size of US$6.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2022-2030.The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 10.8% CAGR
The Tumor / Cancer Markers market in the U.S. is estimated at US$1.1 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 10.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 6.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.Select Competitors (Total 84 Featured) -
- 20/20 Genesystems, Inc.
- Abbott Diagnostics
- AC Immune SA
- Acuamark Diagnostics
- Advanced Cell Diagnostics, Inc.
- Affimedix, Inc.
- Agilent Technologies, Inc.
- Alere, Inc.
- Alexion Pharmaceuticals, Inc.
- ARUP Laboratories
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 20/20 Genesystems, Inc.
- Abbott Diagnostics
- AC Immune SA
- Acuamark Diagnostics
- Advanced Cell Diagnostics, Inc.
- Affimedix, Inc.
- Agilent Technologies, Inc.
- Alere, Inc.
- Alexion Pharmaceuticals, Inc.
- ARUP Laboratories
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 114 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 3.9 Billion |
Forecasted Market Value ( USD | $ 6.5 Billion |
Compound Annual Growth Rate | 6.6% |
Regions Covered | Global |